Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Cortland › NPI 1740287531
Hospital

Guthrie Cortland Medical Center

Guthrie Cortland Medical Center was paid $28.20M by Medicaid between Jul 2019 and Dec 2024, across 256 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoGUTHRIE CORTLAND MEDICAL CENTER
CORTLAND, NY 13045
33aNPI1740287531assigned 07/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.20M
24GClaims534,308
24DCodes billed256
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#45 of 231
Median peer was paid$561K
This provider vs. median50×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201923,958$1.02M
202075,374$2.97M
202199,547$4.43M
2022114,859$9.44M
2023123,711$6.23M
2024incomplete96,859$4.12M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 20,526 19,171 $3.85M
36415 Collection of venous blood by venipuncture 8.0% 70,591 29,260 $2.26M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.3% 8,941 8,547 $1.77M
96361 Intravenous infusion, hydration; each additional hour 5.5% 6,281 5,507 $1.54M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.1% 10,659 10,005 $1.44M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5.1% 6,829 2,694 $1.43M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.9% 3,352 3,253 $1.10M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.4% 4,379 3,582 $950K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.1% 3,485 3,383 $862K
45380 Colonoscopy, flexible; with biopsy, single or multiple 2.7% 731 723 $752K
80053 Comprehensive metabolic panel 2.7% 28,893 24,934 $751K
70450 Computed tomography, head or brain; without contrast material 2.4% 2,291 2,249 $673K
244 more codes
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2.4% 1,083 $664K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 2,073 $652K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.1% 1,093 $581K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.9% 1,312 $540K
81025 1.9% 2,881 $527K
0202U Oncology (prostate), multianalyte, gene expression profiling 1.5% 5,991 $419K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 1,283 $395K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.4% 1,380 $395K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 2,027 $389K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 966 $364K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.3% 1,925 $355K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 4,453 $336K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.1% 7,288 $307K
59025 Fetal non-stress test 1.1% 916 $306K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.0% 3,323 $285K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,712 $276K
97162 <1% 1,031 $265K
93975 <1% 680 $229K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,691 $196K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,809 $161K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,731 $149K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,573 $123K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,334 $111K
76801 <1% 1,052 $109K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,033 $107K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,468 $98K
76830 Ultrasound, transvaginal <1% 1,429 $92K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,316 $88K
84443 Thyroid stimulating hormone (TSH) <1% 8,891 $87K
86900 <1% 1,731 $85K
88342 <1% 224 $85K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,951 $83K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,537 $83K
80048 Basic metabolic panel (calcium, ionized) <1% 3,945 $77K
96367 <1% 738 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 28,936 $75K
80061 Lipid panel <1% 5,909 $74K
12001 <1% 154 $73K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,030 $71K
97161 <1% 311 $68K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 722 $58K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 554 $58K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 260 $56K
83880 <1% 1,534 $47K
86850 <1% 1,665 $43K
83036 Hemoglobin; glycosylated (A1C) <1% 5,117 $43K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 79 $42K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 788 $39K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,778 $38K
71046 Radiologic examination, chest; 2 views <1% 5,256 $37K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 388 $36K
76819 Fetal biophysical profile; without non-stress testing <1% 332 $34K
G0378 Hospital observation service, per hour <1% 1,721 $33K
82607 <1% 2,466 $32K
82728 <1% 2,340 $30K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,283 $27K
82746 <1% 2,048 $26K
84439 <1% 2,880 $23K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,773 $22K
71271 <1% 235 $21K
93017 <1% 134 $21K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,947 $21K
93971 <1% 339 $21K
94060 <1% 82 $19K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 78 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 487 $18K
83550 <1% 2,372 $17K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,612 $16K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,918 $16K
87480 <1% 1,062 $16K
76770 <1% 79 $15K
87510 <1% 1,049 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 348 $15K
90715 <1% 558 $15K
85027 <1% 4,349 $15K
87660 <1% 1,091 $15K
71250 <1% 172 $15K
83540 <1% 2,564 $14K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,402 $14K
86803 <1% 1,618 $13K
84702 <1% 1,891 $11K
12002 <1% 24 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 274 $11K
86901 <1% 806 $11K
81001 <1% 8,206 $10K
86140 <1% 3,698 $9K
87186 <1% 1,742 $8K
73564 <1% 718 $8K
94726 <1% 147 $8K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 290 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,794 $7K
85610 <1% 2,700 $7K
84480 <1% 600 $7K
83735 <1% 3,970 $7K
87081 <1% 2,713 $7K
74018 <1% 305 $7K
87507 <1% 28 $7K
85651 <1% 2,221 $6K
70551 Magnetic resonance imaging, brain; without contrast material <1% 15 $6K
96375 Therapeutic injection; each additional sequential IV push <1% 6,488 $5K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 24 $4K
87340 <1% 910 $4K
76641 <1% 44 $4K
81003 <1% 6,130 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $4K
71045 Radiologic examination, chest; single view <1% 4,790 $4K
82570 <1% 778 $4K
82043 <1% 632 $3K
82962 <1% 2,552 $3K
74183 <1% 12 $3K
73130 <1% 793 $3K
87468 <1% 81 $3K
80076 <1% 366 $3K
87070 <1% 527 $3K
0352U <1% 153 $3K
73610 <1% 945 $3K
86780 <1% 210 $3K
70496 <1% 13 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 443 $3K
86762 <1% 503 $3K
84481 <1% 185 $3K
73630 <1% 854 $3K
87449 <1% 127 $2K
73030 <1% 370 $2K
84403 <1% 78 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 13 $2K
88304 <1% 77 $2K
87077 <1% 573 $2K
87807 <1% 231 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 75 $2K
84703 <1% 5,695 $2K
J1756 Injection, iron sucrose, 1 mg <1% 192 $2K
83690 <1% 6,219 $2K
83655 <1% 143 $2K
87478 <1% 81 $2K
87484 <1% 81 $2K
87469 <1% 81 $2K
70486 <1% 25 $1K
72110 <1% 40 $1K
73110 <1% 345 $1K
82784 <1% 98 $1K
84484 <1% 7,537 $1K
85652 <1% 680 $1K
86706 <1% 149 $1K
82550 <1% 1,343 $1K
87040 <1% 3,342 $1K
86618 <1% 128 $927.99
87205 <1% 558 $851.01
82950 <1% 175 $824.19
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 17 $820.96
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,596 $796.07
70498 <1% 25 $789.43
97165 <1% 13 $787.63
86704 <1% 71 $703.21
83516 <1% 25 $685.36
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 366 $649.91
85378 <1% 1,437 $581.25
83605 <1% 3,948 $567.92
81002 <1% 287 $527.08
82105 <1% 40 $503.86
84100 <1% 548 $490.51
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,118 $466.72
84436 <1% 78 $463.44
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13 $443.37
87521 Neg quan hep c or qual rna <1% 14 $437.56
86617 <1% 14 $423.15
83615 <1% 103 $413.97
85730 <1% 316 $413.04
85014 <1% 131 $377.47
84550 <1% 112 $361.58
A9585 Injection, gadobutrol, 0.1 ml <1% 622 $351.86
73590 <1% 91 $323.82
J7030 Infusion, normal saline solution , 1000 cc <1% 4,879 $303.39
85018 <1% 155 $297.37
86038 <1% 29 $297.31
94729 <1% 147 $288.14
80074 <1% 12 $267.98
84146 <1% 12 $266.84
82248 <1% 63 $266.60
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 602 $265.72
84152 <1% 13 $239.07
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,746 $223.79
84153 <1% 12 $169.19
88302 <1% 12 $165.20
86705 <1% 13 $150.89
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,601 $149.02
86431 <1% 28 $139.88
84479 <1% 24 $120.78
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 411 $105.87
85379 <1% 287 $105.62
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,705 $104.08
81015 <1% 41 $95.72
86308 <1% 110 $91.69
85007 <1% 77 $85.57
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,752 $83.92
J7050 Infusion, normal saline solution, 250 cc <1% 685 $72.35
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,322 $70.44
J8540 Dexamethasone, oral, 0.25 mg <1% 776 $69.50
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 286 $66.89
76981 <1% 122 $60.28
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,414 $57.88
J0690 Injection, cefazolin sodium, 500 mg <1% 1,077 $57.54
82805 <1% 224 $55.57
86787 <1% 12 $53.03
J2704 Injection, propofol, 10 mg <1% 5,962 $41.97
96376 <1% 2,394 $38.19
86592 <1% 12 $37.42
80143 <1% 1,316 $37.28
80179 <1% 1,276 $37.28
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,373 $29.17
J7060 5% dextrose/water (500 ml = 1 unit) <1% 246 $27.74
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,173 $24.74
J1644 Injection, heparin sodium, per 1000 units <1% 663 $24.20
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 88 $18.82
J1170 Injection, hydromorphone, up to 4 mg <1% 351 $11.05
J2060 Injection, lorazepam, 2 mg <1% 792 $9.19
J1650 Injection, enoxaparin sodium, 10 mg <1% 90 $6.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,153 $6.02
82947 <1% 13 $4.72
J7120 Ringers lactate infusion, up to 1000 cc <1% 384 $4.69
82272 <1% 12 $4.23
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 888 $1.63
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,370 $1.18
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 516 $0.30
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,440 $0.24
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 124 $0.16
J3490 Unclassified drugs 0% 238 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 70 $0.00
73502 0% 12 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 24 $0.00
J1815 Injection, insulin, per 5 units 0% 39 $0.00
82270 0% 13 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 38 $0.00
J3372 Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg 0% 135 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 165 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 357 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 103 $0.00
73080 0% 27 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 25 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 36 $0.00
82009 0% 14 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 27 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 12 $0.00
73140 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAGGIOMO, LUCIA (VP)
Same official

Other billing entities under SAGGIOMO, LUCIA

Full network →
ProviderLocationPaid
Robert Packer HospitalTowanda, PA$5K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.